Similar Items: The burden of serious adverse drug reactions in South Africa
- The immunopathogenic mechanism of severe cutaneous adverse reactions to first line anti-tuberculosis drugs
- The genetics of lithium-induced adverse drug reactions in bipolar disorder patients : a pilot study
- Prevalence of anxiety and depression in a predominantly HIV-infected population with severe cutaneous adverse drug reactions
- Adverse drug reactions in paediatric in-patients in a South African tertiary hospital
- Risk factors and critical thresholds for glucocorticoid-induced ocular adverse reactions in children: implications for muscle and neuromuscular disease management
- Long-term HIV and tuberculosis outcomes in co-infected patients with treatment limiting severe cutaneous adverse reactions
Author: Cohen, Karen
- A randomised controlled trial of N-acetylcysteine in the management of anti-tuberculosis drug-induced liver injury
- Morbidity from antiretroviral metabolic effects in Africa: The Mama Study
- Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
- The burden of serious adverse drug reactions in South Africa
- Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis
- N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review